{"id":368505,"date":"2022-07-01T05:55:36","date_gmt":"2022-07-01T00:25:36","guid":{"rendered":"https:\/\/www.www.bullfrag.com\/biontech-and-pfizer-test-universal-coronavirus-vaccine\/"},"modified":"2022-07-01T05:55:36","modified_gmt":"2022-07-01T00:25:36","slug":"biontech-and-pfizer-test-universal-coronavirus-vaccine","status":"publish","type":"post","link":"https:\/\/www.bullfrag.com\/biontech-and-pfizer-test-universal-coronavirus-vaccine\/","title":{"rendered":"BioNTech and Pfizer test universal coronavirus vaccine"},"content":{"rendered":"
Branding a brand requires a well-planned marketing strategy with the idea of \u200b\u200bpositioning a concept, services or products. It’s not easy to make these stand out from the rest, 6 even less so when budgets are tight.<\/p>\n
In that scenario, co-branding can be a perfect cost-saving solution. A well thought out strategic alliance can make the difference between success and failure.<\/p>\n
An example of joint work is the one that was announced this Thursday, June 30, between the German company BioNTech and the United States pharmaceutical company Pfizer.<\/p>\n
The two firms, which have already made vaccines together, confirmed that they will start human trials of a new generation of injections for the coronavirus that would serve, if successful, as a generic drug for covid.<\/p>\n
<\/p>\n
They are not small companies. Pfizer is one of the world’s largest-selling pharmaceutical multinationals, with 2021 annual revenues of more than $81 billion.<\/p>\n
The pandemic created a great business opportunity for Pfizer to grow its reputation as a vaccine manufacturer and its revenues.<\/p>\n
After the record registered in 2021, Pfizer expects to bill around US$100 billion in 2022.<\/p>\n
Of that total, the projection is that 32 billion will come from the sale of its vaccine developed together with BioNTech.<\/p>\n